SCHEMBL7047741

SCHEMBL7047741

CN(c1cc(N(C(=O)OC(C)(C)C)[N+](=O)[O-])ccc1C(F)(F)F)C1CC1

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.36
CACNA1G O43497 1/20 0.33
CACNA1B Q00975 1/20 0.33
CACNA1C Q13936 1/20 0.33
MAPT P10636 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
RXRA P19793 1/20 0.32
NR1H2 P55055 1/20 0.32
NR1H3 Q13133 1/20 0.32
LMNA P02545 2/20 0.32
POLB P06746 1/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
NPC1 O15118 1/20 0.30
HTT P42858 1/20 0.30
RAB9A P51151 1/20 0.30
GPR119 Q8TDV5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7039773 0.81 NR1H3 (0.33) ALDH1A1CACNA1GCACNA1BCACNA1CRXRA
SCHEMBL17336687 0.81 LMNA (0.36) ALDH1A1CACNA1GCACNA1BCACNA1CMAPT
SCHEMBL17336893 0.80 NOTUM (0.36) CACNA1GCACNA1BCACNA1CRXRANR1H2
SCHEMBL5558208 0.78 RBP4 (0.36)
SCHEMBL6872851 0.78 RXRA (0.36) ALDH1A1CACNA1GCACNA1BCACNA1CRXRA
SCHEMBL7045105 0.77 LMNA (0.33) CACNA1GCACNA1BCACNA1CRXRANR1H2
SCHEMBL7113987 0.76 RXRA (0.35) ALDH1A1RXRANR1H2NR1H3LMNA
SCHEMBL6881881 0.75 SLC6A9 (0.45) ALDH1A1MAPTLMNAHTT
SCHEMBL6607932 0.74 LMNA (0.35) ALDH1A1MAPTRXRANR1H2NR1H3
SCHEMBL6622947 0.71 POLQ (0.35) ALDH1A1MAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1474416-A1 DIHYDROBENZODIAZEPIN-2-ONE-DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2004-11-10 EP disclosed
WO-2003066623-A1 DIHYDROBENZODIAZEPIN-2-ONE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2003-08-14 WO disclosed